PulseAugur / Brief
EN
LIVE 20:23:42

Brief

last 24h
[1/1] 222 sources

Multi-source AI news clustered, deduplicated, and scored 0–100 across authority, cluster strength, headline signal, and time decay.

  1. Tainkang: Subsidiary's Stomach and Intestine Pill Receives Drug Registration Certificate

    Taien Kang's subsidiary, Anhui Taien Kang Pharmaceutical Co., Ltd., has received a Drug Registration Certificate from China's National Medical Products Administration for its "Hewei Zhengchang Pill." This traditional Chinese medicine is classified as a Category 4 drug and is intended to warm the stomach, regulate qi, and relieve pain, addressing symptoms like abdominal pain and diarrhea. The company acknowledges that future sales performance is subject to market and policy uncertainties. AI